These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 4140746)
1. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer. Giles GR; Hall R; Brennan TG; Worthy TS Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746 [No Abstract] [Full Text] [Related]
2. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer. Klaassen DJ; Rapp E Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046 [No Abstract] [Full Text] [Related]
3. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma. Lokich JJ; Skarin AT Cancer Chemother Rep; 1972 Oct; 56(5):653-7. PubMed ID: 4569058 [No Abstract] [Full Text] [Related]
4. Oral administration of fluorouracil. A preliminary trial. Nadler SH Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137 [No Abstract] [Full Text] [Related]
5. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine. Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460 [TBL] [Abstract][Full Text] [Related]
7. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group]. Taguchi T Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400 [TBL] [Abstract][Full Text] [Related]
8. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma. Trux F Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880 [No Abstract] [Full Text] [Related]
9. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors. Cohen SM; Weiner MJ; Greenspan EM Cancer Chemother Rep; 1972 Dec; 56(6):751-4. PubMed ID: 4660631 [No Abstract] [Full Text] [Related]
10. Therapy of advanced gastrointestinal cancer with the nitrosoureas. Moertel CG Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872 [No Abstract] [Full Text] [Related]
11. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms. Gailani S; Kutcher J J Med; 1973; 4(4):209-18. PubMed ID: 4520348 [No Abstract] [Full Text] [Related]
12. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer]. Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810 [TBL] [Abstract][Full Text] [Related]
13. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma. Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274 [No Abstract] [Full Text] [Related]
14. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas. Tormey DC; Gailani S; Leone L Oncology; 1974; 29(3):244-8. PubMed ID: 4415043 [No Abstract] [Full Text] [Related]
15. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer. Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144 [No Abstract] [Full Text] [Related]
16. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study. Hoogstraten B; Gottlieb JA; Caoili E; Tucker WG; Talley RW; Haut A Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783 [No Abstract] [Full Text] [Related]
18. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma]. Togni P; Sessa C; Varini M; Cavalli F Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002 [TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trial. Omura GA; Bartolucci AA; Lessner HE; Hill GJ Cancer Treat Rep; 1984 Jun; 68(6):929-30. PubMed ID: 6547369 [No Abstract] [Full Text] [Related]